TickerFacts.

ARS Pharmaceuticals, Inc. (SPRY): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

99.29M
As of 2025-12-31
99.44M
As of 2026-06-30
+1.9%
3-year compound annual growth
2020-12-31: 34.70M2021-12-31: 30.37M2022-12-31: 93.94M2023-12-31: 96.41M2024-12-31: 97.95M2025-12-31: 99.29M99.29M
2020-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3199.29M+1.4%2026-03-09, Balance as of period end
2024-12-3197.95M+1.6%2026-03-09, Balance as of period end
2023-12-3196.41M+2.6%2025-03-20, Balance as of period end
2022-12-3193.94Mn/c2024-03-21, Balance as of period end
2021-12-3130.37Mn/c2023-03-23, Balance as of period end
2020-12-3134.70Mn/a2022-03-31, Balance as of period end